Ticker change coming...Shorts will get burn if they will not cover or do damage control. ZFGN has 82M dollars in cash!
The proposed merger will result in a combined publicly traded, clinical-stage biopharmaceutical company operating under a new name, Larimar Therapeutics, Inc.